课题基金 / 基金详情

Cancer Biology

Cancer Biology
癌症生物学
批准号:
7107585
负责人:
BRUCE E. MAGUN
金额:
$0.96万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-05 至 2010-05-31

项目摘要

项目成果

BRUCE E. MAGUN的其他基金

相似基金

相关文献

中文摘要
翻译
癌症生物学项目是OHSU癌症研究所基础科学研究的基础。癌症生物学计划的总体目标是研究潜在的细胞和分子机制,涉及癌症的发展和正常和异常细胞生长的调节。该计划的科学推力在两个相关的研究领域:致癌/遗传不稳定性和信号转导。该计划共有34个正式成员和2个准成员,获得了2510万美元的赠款资金
英文摘要
The Cancer Biology program constitutes the foundation of basic science research of the OHSU Cancer institute. The overall goal of the Cancer Biology Program is to investigate the underlying cellular and molecular mechanisms involved in the development of cancer and in the regulation of both normal and abnormal cell growth. The scientific thrust of the program is in two related areas of investigation: Carcinogenesis/Genetic Instability and Signal Transduction. There are with 34 full and 2 associate members in the program with $25.1 million in grant funding stemming from 83 projects. Of these, 26 grants provide $7.4 million in NCI funding. Members of the Carcinogenesis/Genetic Instability group focus their studies around cell cycle control, the regulation of apoptosis, and the relationship of these events to the development of genetic instability and cancer. The members of the Signal Transduction group focus their studies around general signaling mechanisms of relevance to regulation of normal and cancer cell growth: the integrated function of growth factors and their receptors, kinase-mediated signaling phenomena, and the regulation of transcription that lies downstream of the aforementioned events. Because of the seamless nature of cellular regulation that is relevant to the cancer problem, there is a great deal of overlap between the research interests of the two groups. These shared interests have led to an abundance of collaborations and interactivity among the members of the Cancer Biology program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting IL-1beta as a strategy for symptom control in cancer
Targeting IL-1beta as a strategy for symptom control in cancer
Targeting IL-1beta as a strategy for symptom control in cancer
Targeting IL-1beta as a strategy for symptom control in cancer
国内基金
海外基金
RKTG对ERK信号通路的调控和肿瘤生成的影响